Literature DB >> 7531188

Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system.

A M Musso1, G L Zanusso, M L Bonazzi, G Tomelleri, B Bonetti, G Moretto, M Vio, S Monaco.   

Abstract

Endothelial intercellular adhesion molecule-1 (ICAM-1) and glycoprotein E-selectin (ELAM-1) allow the homing of leukocytes to inflammation sites. A circulating form of ICAM-1 markedly increases in inflammatory CNS disorders. In the present study, the serum levels of ICAM-1, ELAM-1 and tumor necrosis factor-alpha (TNF-alpha) were measured in patients with acute (AIDP) and chronic (CIDP) inflammatory demyelinating polyneuropathies and cryoglobulinemic neuropathy (CGN). Immunoenzymometric assays revealed increased sICAM-1 levels in some of these patients; furthermore, high titres of ELAM-1 and TNF-alpha were detected in two patients with AIDP and one patient with CGN. Our data extend previous observations on inflammatory PNS disorders by showing that, in addition to ICAM-1, ELAM-1 also represents a useful marker of endothelial activation and that, taken together, the two molecules may serve as an indicator of specific pathogenetic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531188     DOI: 10.1007/bf02339236

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  16 in total

1.  A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review.

Authors:  M Honavar; J K Tharakan; R A Hughes; S Leibowitz; J B Winer
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

Review 2.  Circulating adhesion molecules in disease.

Authors:  A J Gearing; W Newman
Journal:  Immunol Today       Date:  1993-10

3.  A form of circulating ICAM-1 in human serum.

Authors:  R Rothlein; E A Mainolfi; M Czajkowski; S D Marlin
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

4.  Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders.

Authors:  R Seth; F D Raymond; M W Makgoba
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

5.  Cell adhesion in the immune system.

Authors:  C R Mackay; B A Imhof
Journal:  Immunol Today       Date:  1993-03

6.  Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

Authors:  P Rieckmann; K Nünke; M Burchhardt; M Albrecht; J Wiltfang; M Ulrich; K Felgenhauer
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

Review 7.  Inflammatory mediators in demyelinating disorders of the CNS and PNS.

Authors:  H P Hartung; S Jung; G Stoll; J Zielasek; B Schmidt; J J Archelos; K V Toyka
Journal:  J Neuroimmunol       Date:  1992-10       Impact factor: 3.478

8.  Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.

Authors:  N Tsukada; K Miyagi; M Matsuda; N Yanagisawa
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

9.  Human peripheral nerve macrophages in normal and pathological conditions.

Authors:  B Bonetti; S Monaco; C Giannini; S Ferrari; G Zanusso; N Rizzuto
Journal:  J Neurol Sci       Date:  1993-09       Impact factor: 3.181

10.  A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.

Authors:  B N Cronstein; S C Kimmel; R I Levin; F Martiniuk; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  7 in total

1.  The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.

Authors:  Chaoling Dong; Steven P Palladino; Eric Scott Helton; Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2016-07-26       Impact factor: 17.088

Review 2.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 3.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

4.  Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1.

Authors:  Luis Jaramillo-Valverde; Kelly S Levano; Isolina Villanueva; Meylin Hidalgo; Marco Cornejo; Pilar Mazzetti; Mario Cornejo-Olivas; Cesar Sanchez; Julio A Poterico; Julio Valdivia-Silva; Heinner Guio
Journal:  Mol Genet Genomic Med       Date:  2019-08-28       Impact factor: 2.183

Review 5.  Progress in Hematopoietic Stem Cell Transplantation for CIDP.

Authors:  Zhen Qin; Qianyi Huang; Jiangying Zou; Lisha Tang; Zhiping Hu; Xiangqi Tang
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

6.  Pro-inflammatory cytokines and leukocyte integrins associated with chronic neuropathic pain in traumatic and inflammatory neuropathies: Initial observations and hypotheses.

Authors:  Chaoling Dong; Eroboghene E Ubogu
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

7.  Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells.

Authors:  Thomas Grüter; Alina Blusch; Jeremias Motte; Melissa Sgodzai; Hussein Bachir; Rafael Klimas; Björn Ambrosius; Ralf Gold; Gisa Ellrichmann; Kalliopi Pitarokoili
Journal:  J Neuroinflammation       Date:  2020-05-06       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.